Citadel Advisors’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
Other funds holding NH
HCM
BCM
ASN
NFSG
Citadel Advisors's NH Position: Q4 2022 in Review
Citadel Advisors sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 3,197 shares — an estimated $12K sold.
Citadel Advisors first reported a position in NH in Q1 2017 and held it in 14 quarters. The position peaked at $152K in Q1 2021. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.
- Citadel Advisors reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
- Citadel Advisors sold 3,197 NantHealth, Inc shares in Q4 2022, an estimated $12K.
- Citadel Advisors first reported a position in NantHealth, Inc in Q1 2017 and held it in 14 quarters.
- Citadel Advisors's NantHealth, Inc position peaked at $152K in Q1 2021.
- 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.